BANK OF AMERICA CORP /DE/ - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 71 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$3,583,000
+1499.6%
95,126
+620.9%
0.00%
Q4 2020$224,000
+187.2%
13,195
-20.6%
0.00%
Q3 2020$78,000
-39.1%
16,623
-20.7%
0.00%
Q2 2020$128,000
+220.0%
20,963
+18.5%
0.00%
Q1 2020$40,000
-64.3%
17,689
-27.5%
0.00%
Q4 2019$112,000
-8.9%
24,389
-23.5%
0.00%
Q3 2019$123,000
-42.5%
31,871
-10.1%
0.00%
Q2 2019$214,000
-90.6%
35,452
-79.1%
0.00%
Q1 2019$2,270,000
+65.7%
169,348
+14.9%
0.00%
Q4 2018$1,370,000
-7.7%
147,324
+38.2%
0.00%
Q3 2018$1,485,000
-18.9%
106,625
-8.0%
0.00%
Q2 2018$1,831,000
-7.8%
115,868
+0.3%
0.00%
Q1 2018$1,985,000
+48.4%
115,532
+89.4%
0.00%
Q4 2017$1,338,000
+0.1%
61,010
+86.7%
0.00%
Q3 2017$1,336,000
+195.6%
32,673
+117.3%
0.00%
Q2 2017$452,000
-32.6%
15,034
-19.0%
0.00%
Q1 2017$671,000
-23.7%
18,558
+5.8%
0.00%
Q4 2016$879,000
+27.0%
17,533
+32.9%
0.00%
Q3 2016$692,000
+15.7%
13,194
-8.7%
0.00%
Q2 2016$598,000
+469.5%
14,447
+458.0%
0.00%
Q1 2016$105,000
-47.8%
2,589
-46.6%
0.00%
Q4 2015$201,000
+3920.0%
4,851
+1506.3%
0.00%
Q3 2015$5,000
-99.2%
302
-98.7%
0.00%
Q2 2015$598,000
+59700.0%
24,089
+41432.8%
0.00%
Q1 2015$1,000
-98.2%
58
-97.2%
0.00%
Q4 2014$57,000
+62.9%
2,100
-29.6%
0.00%
Q3 2014$35,0002,985
+22861.5%
0.00%
Q1 2014$0130.00%
Other shareholders

There were no reported owners of FIVE PRIME THERAPEUTICS INC in Q4 2014.

NameSharesValueWeighting ↓
View complete list of FIVE PRIME THERAPEUTICS INC shareholders